NCT01443780View on ClinicalTrials.gov

Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population in Sweden

NACompletedINTERVENTIONAL
Enrollment

443

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Cardiovascular MortalityCardiac Function
Interventions
DIETARY_SUPPLEMENT

Selenium and ubiquinon (Q10) combined

A combination of 200 mg/day of coenzyme Q10 (Bio-Quinon 100 mg B.I.D, Pharma Nord, Vejle, Denmark) and 200 µg/day of organic selenium (SelenoPrecise 200 µg, Pharma Nord), or placebo

Trial Locations (1)

Se-581 85

Dept of Cardiology, University Hospital of Linköping, Linköping

Sponsors

Collaborators (1)

Pharma Nord
All Listed Sponsors
collaborator

Ostergotland County Council, Sweden

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Pharma Nord

INDUSTRY

lead

University Hospital, Linkoeping

OTHER

NCT01443780 - Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population in Sweden | Biotech Hunter | Biotech Hunter